Live feed08:00:00·112dNEWSReleasevia QuantisnowEnsysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose ProtectionByQuantisnow·Wall Street's wire, on your screen.ENSC· Ensysce Biosciences Inc.Health Care
